Neurodegenerative Flashcards
(53 cards)
Most common degenerative disorder
1st Alzheimer’s
2nd IPD
Most common familial type of IPD
PARK-8 gene: AD, chromosome 12, enzyme LRRK-2 (leucine rich repeat kinase)
Onset of postural instability in Parkinson’s disease vs P+
IPD 8-10 years
MSA: 5 years
PSP: 2 years
Most initial non-motor symptoms in IPD
Anosmia/hyposmia
Wilson disease genetics
Autosomal recessive ch13, mutation in ATP7B
IPD PET scan findings: decreased uptake in what areas
Dopaminergic dorsal striatum (🟢putamen🟢 < caudate) , then nigrostriatal pathway
Most likely to cause hallucination from IPD medications
Amanatadine and dopamine agonists > carbidopa/levodopa
Most likely to cause dyskinesia from IPD medications
Levodopa/carbidopa > dopamine agonists and COMT-I
Best option of DBS for dyskinesia in IPD
DBS-GPi
Contraindications of DBS-STN in IPD
1- Severe depression and psychosis
2-Cognitive decline
3-Age > 70
4-Brain atrophy
5-On-phase Freezing of gait
What is the goal of DBS-STN
Decrease Dopaminergic medications by 50%
Preferred surgical management of tremor in IPD
Thalamotomy or DBS on ventral intermediate nucleus (VIM)
Treatment of restless leg syndrome
Dopamine agonist or gabapentin
Treatment of ٍREM sleep disorders
Clonazepam or melatonin in elderly
Treatment of orthostatic hypotension in IPD
Fludrocortisone
Increase fluid intake
Midodrine
List of tauopathies (5)
1-Alzheimers’ disease
2-FTD
3-CBD
4-PSP
5-pick disease
List of syncleinopathies (5)
PALMR
1-Parkinson’s disease
2- Autonomic failure
3-Lewy body dementia
4-MSA
5-Spontaneous REM sleep behavioral disorder
FDG PET in different types of P+
MSA: putamen and/or cerebellar
LBD: occipital
PSP: prefrontal cortex (anterior cingulate)
CBD: frontopraietal
——-
Alzheimer’s: parietal-temporal > frontal
FTD: frontotemporal
Pathology in different Parkinson’s plus syndromes
MSA: oligodendro-glial cytoplasmic inclusion (GCI)
DLB: Lewy bodies
PSP: tufted Astro yes
CBD: globose neurofibrillary tangles and ballooned neurons (achromasia)
Wilson disease imaging findings and pathology
-CT brain: symmetrical hypodensity of putamen
-MRI T2 and FLAIR: bil symmetrical hyper-intense basal ganglia (putamen), thalami, and dentate nuclei. midbrain face of panda sign.
-Pathology: Alzheimer’s type 2 cells and opalski cells
MCC of toxin induced Parkinsonism (environmental) and typical location
Manganese
Globus pallidus and STN
Huntington’s disease genetics
AD on Chromosome 4, CAG repeat sequence
⚫️CAG >= 40 : high penetrance + have the disease
⚫️CAG 36-39 : reduced penetrance + have the disease
⚪️CAG 27-35 : intermediate penetrance + don’t have the disease
⚪️CAG <27 : normal
Huntington’s disease imaging findings
MRI: unilateral or bilateral caudate atrophy and dilated lateral ventricles
PET: unilateral or bilateral caudate hypo-metabolism
First line Tx for Sydenham’s chorea
Valproic acid